Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Aquila reports preliminary results of phase II trial of pneumococcal vaccine

Oct. 16, 1998

New compound reported in clinical development at Lilly

Oct. 15, 1998

Immunomodulating thalidomide analogues patented by Gruenenthal

Oct. 14, 1998

Ono's new PGE2 derivatives show binding affinity for EP2 receptors

Oct. 13, 1998

Development status updated for 3M's imiquimod analogue R-848

Oct. 7, 1998

La Jolla enrolls patients in phase II/III trial for lupus treatment

Oct. 6, 1998

Ono discloses compounds with high binding affinity for prostanoid EP4 receptors

Oct. 6, 1998

Chiroscience identifies new target for autoimmune disease therapy

Oct. 5, 1998

Merck describes new ascomycin derivatives with improved therapeutic potential

Oct. 5, 1998

3M presents first clinical results for potent new immunomodulator

Oct. 5, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...